Top Markets
Coin of the day
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Rank in Stocks #32811
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Share Price
$2.22
Last synced: 2026-08-17
Market Cap
$9.03M
Change (1 day)
-3.13%
Change (1 year)
-24.26%
Country
JP
Trade PhoenixBio Co., Ltd. (6190)

Category

Stock split history for PhoenixBio Co., Ltd. (6190)
PhoenixBio Co., Ltd. stock (symbol: 6190) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 18, 2026.
One 6190 share bought prior to Aug 18, 2026 would equal to 0 6190 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE